EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel Prognostic and Predictive miRNA Biomarkers Shape the Landscape of T Cell Dysfunction in Cancer

Hong-Jiu Wang iD, Xiao-Ling Wen iD, Zhe-Yu Wu, Na Wang, Shu-Heng Fu, Fei-Fan Xiong, Jiang-Ying Liang, Deng-Hui Guo, Si-Rui Li, Jie Shen, Xiao-Ling Gao iD, Zhen-Zhen Wang

Journal of Cellular and Molecular Medicine · 2026-04 · 30 (7)

DOI: 10.1111/jcmm.71117 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 02.04.2026. Verfasst von Hong-Jiu Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Intelligent Medicine and Technology, Big Data Research Center, Hainan Medical University, Haikou, China. Hauptthemen laut MEDLINE: MicroRNAs, Biomarkers, Tumor, Neoplasms, T-Lymphocytes. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hainan Province, National Natural Science Foundation of China, Education Department of Hainan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

T cell dysfunction (TCD) plays a critical role in cancer progression and significantly impacts patient outcomes. Despite its importance, the exact molecular mechanisms underlying TCD remain poorly understood. To address this, we constructed a comprehensive pan‐cancer landscape of TCD, with a particular focus on identifying miRNA biomarkers that define and predict TCD severity. Our analysis revealed six key miRNAs (miR‐203b, miR‐214, miR‐4772, miR‐141, miR‐200a, and miR‐200b) that were closely associated with varying degrees of TCD. These prognostic miRNAs not only exhibited distinct expression patterns across four identified TCD subtypes (from low to high TCD severity) but also demonstrated strong predictive performance in classifying patients with different levels of TCD. The identified miRNA signatures serve as reliable biomarkers for stratifying patients into high‐risk and low‐risk groups, with higher TCD levels correlating to poorer overall survival. In addition to miRNA biomarkers, we observed that patients with severe TCD exhibited increased infiltration of immune cells and macrophages and dysregulation of DNA methylation patterns. Patients with higher degrees of TCD displayed low methylation levels, which further contributed to the progression of T cell dysfunction. In summary, our study highlights the pivotal role of miRNA biomarkers in shaping the landscape of T cell dysfunction across cancers. These miRNAs serve as both prognostic indicators and predictive tools, enabling accurate classification of TCD severity and offering new avenues for therapeutic exploration and patient stratification in cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsBiomarkers, TumorNeoplasmsT-LymphocytesHumansPrognosisGene Expression Regulation, NeoplasticDNA MethylationGene Expression ProfilingTumor Microenvironment

Stichwörter der Autor:innen

T cell dysfunctioncancer subtypeimmunocompetencemiRNApan‐cancerprognosis biomarkertumour microenvironment

Substanzen

MicroRNAsBiomarkers, Tumor

Autor:innen und Institutionen

  • School of Intelligent Medicine and Technology, Big Data Research Center, Hainan Medical University, Haikou, China.
  • College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China.
  • Shanghai Jiao Tong University, Shanghai, China.
  • The Medical Laboratory Center, Hainan General Hospital, Haikou, China.
  • Key Laboratory of Reproductive Health Diseases Research and Translation (Hainan Medical University), Ministry of Education, The First Affiliated Hospital of Hainan Medical University, Hainan Medical University, Haikou,…

ORCID-Profile: Hong-Jiu Wang, Xiao-Ling Wen, Xiao-Ling Gao

Förderung

  • Natural Science Foundation of Hainan Province
  • National Natural Science Foundation of China
  • Education Department of Hainan Province
  • Key Research and Development Project of Hainan Province
  • Hainan Province Clinical, Medical Center

Zitieren

APA

Wang, H. J., Wen, X. L., Wu, Z. Y., Wang, N., Fu, S. H., Xiong, F. F., Liang, J. Y., Guo, D. H., Li, S. R., Shen, J., Gao, X. L., & Wang, Z. Z. (2026). Novel Prognostic and Predictive miRNA Biomarkers Shape the Landscape of T Cell Dysfunction in Cancer. Journal of Cellular and Molecular Medicine, 30(7). https://doi.org/10.1111/jcmm.71117

Vancouver

Wang HJ, Wen XL, Wu ZY, Wang N, Fu SH, Xiong FF, et al. Novel Prognostic and Predictive miRNA Biomarkers Shape the Landscape of T Cell Dysfunction in Cancer. Journal of Cellular and Molecular Medicine. 2026;30(7). doi:10.1111/jcmm.71117

BibTeX
@article{Wang2026,
  author = {Wang, Hong-Jiu and Wen, Xiao-Ling and Wu, Zhe-Yu and Wang, Na and Fu, Shu-Heng and Xiong, Fei-Fan and Liang, Jiang-Ying and Guo, Deng-Hui and Li, Si-Rui and Shen, Jie and Gao, Xiao-Ling and Wang, Zhen-Zhen},
  title = {Novel Prognostic and Predictive miRNA Biomarkers Shape the Landscape of T Cell Dysfunction in Cancer},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2026},
  volume = {30},
  number = {7},
  doi = {10.1111/jcmm.71117}
}
Kostenlos starten →